US 9649320
Non-hormonal steroid modulators of NF-κB for treatment of disease
granted A61KA61K31/57A61K31/573
Quick answer
US patent 9649320 (Non-hormonal steroid modulators of NF-κB for treatment of disease) held by ReveraGen BioPharma, Inc. expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ReveraGen BioPharma, Inc.
- Grant date
- Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/57, A61K31/573, A61K31/575, A61P